Abstract:'' Nano-metamaterials '', rationally designed novel class metamaterials with multilevel microarchitectures and both characteristic sizes and whole sizes at the nanoscale, are introduced into the area of drug delivery system (DDS), and the relationship between release profile and treatment efficacy at the single-cell level is revealed for the first time. Fe3+-core-shell-corona nano-metamaterials (Fe3+-CSCs) are synthesized using a dual-kinetic control strategy. The hierarchical structure of Fe3+-CSCs, with a homogeneous interior core, an onion-like shell, and a hierarchically porous corona. A novel polytonic drug release profile occurred, which consists of three sequential stages: burst release, metronomic release, and sustained release. The Fe3+-CSCs results in overwhelming accumulation of lipid reactive oxygen species (ROS), cytoplasm ROS, and mitochondrial ROS in tumor cells and induces unregulated cell death. This cell death modality causes cell membranes to form blebs, seriously corrupting cell membranes to significantly overcome the drug-resistance issues. It is first demonstrated that nano-metamaterials of well-defined microstructures can modulate drug release profile at the single cell level, which in turn alters the downstream biochemical reactions and subsequent cell death modalities. This concept has significant implications in the drug delivery area and can serve to assist in designing potential intelligent nanostructures for novel molecular-based diagnostics and therapeutics.

Nanoparticles with transformable physicochemical properties for overcoming biological barriers

Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management

Polytonic Drug Release via Multi-Hierarchical Microstructures Enabled by Nano-Metamaterials

Smart transformable nanoparticles for enhanced tumor theranostics

Progress, challenges, and future of nanomedicine

Smart and bioinspired systems for overcoming biological barriers and enhancing disease theranostics

New Nanomaterials and Techniques for Tumor-targeted Systems

Transforming Medicine with Nanobiotechnology: Nanocarriers and Their Biomedical Applications

Accelerating the Translation of Nanomaterials in Biomedicine.

Nanoparticles in Medicine: Therapeutic Applications and Developments

Overcoming Vascular Barriers to Improve the Theranostic Outcomes of Nanomedicines

Nanomaterials with changeable physicochemical property for boosting cancer immunotherapy

Nanomedomics

"Targeting Design" of Nanoparticles in Tumor Therapy

Overcoming Hepatic Biotransformation Barrier of Gold Nanoparticles via Au-Se Bond for Enhanced In Vivo Active Targeting

Biologically based strategies for overcoming in vivo barriers with functional nano-delivery systems

Nanoparticle-based medicines in clinical cancer therapy

Principles of nanoparticle design for overcoming biological barriers to drug delivery

Surface Engineering of Nanoparticles toward Cancer Theranostics

Innovative Pharmaceutical Development Based on Unique Properties of Nanoscale Delivery Formulation.

Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery